SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+2.97%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$1.09B
AUM Growth
+$1.09B
(+13%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
14.49%
Top 10 Holdings %
Top 10 Hldgs %
43.03%
Holding
204
New
91
Increased
35
Reduced
20
Closed
37
Top Buys
| 1 |
Sanofi
SNY
|
$49.4M |
| 2 |
AbbVie
ABBV
|
$28.1M |
| 3 |
Johnson & Johnson
JNJ
|
$19M |
| 4 |
LivePerson
LPSN
|
$13.7M |
| 5 |
AstraZeneca
AZN
|
$13.4M |
Top Sells
| 1 |
Novartis
NVS
|
$40.5M |
| 2 |
Bristol-Myers Squibb
BMY
|
$26.8M |
| 3 |
Sarepta Therapeutics
SRPT
|
$12.8M |
| 4 |
Zymeworks
ZYME
|
$11.6M |
| 5 |
Meta Platforms (Facebook)
META
|
$10.9M |
Sector Composition
| 1 | Healthcare | 74.93% |
| 2 | Technology | 9.21% |
| 3 | Industrials | 5.88% |
| 4 | Financials | 3.51% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fate Therapeutics
FATE
$115M
| $9.05M | 0.69% |
109,807
+27,807
| +34% | +$2.29M |
|
27
VistaGen Therapeutics
VTGN
$110M
| $8.9M | 0.68% |
4,177,158
+1,452,158
| +53% | +$3.09M |
|
28
Zai Lab
ZLAB
$3.51B
| $8.78M | 0.67% |
+65,788
| New | +$8.78M |
|
29
Nice
NICE
$8.47B
| $8.61M | 0.66% |
39,481
-35,000
| -47% | -$7.63M |
|
30
Amazon
AMZN
$2.39T
| $8.54M | 0.66% |
2,761
+700
| +34% | +$2.17M |
|
31
Onto Innovation
ONTO
$4.99B
| $8.21M | 0.63% |
+125,000
| New | +$8.21M |
|
|
SGTX
32
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $8.07M | 0.62% |
362,239
-205,221
| -36% | -$4.57M |
|
|
AFMD
33
DELISTED
Affimed
AFMD
| $8.06M | 0.62% |
+1,018,965
| New | +$8.06M |
|
34
Bolt Biotherapeutics
BOLT
$9.29M
| $7.93M | 0.61% |
+241,000
| New | +$7.93M |
|
35
Repare Therapeutics
RPTX
$73.5M
| $7.61M | 0.58% |
248,100
+23,800
| +11% | +$730K |
|
36
Zentalis Pharmaceuticals
ZNTL
$123M
| $7.6M | 0.58% |
175,140
-15,656
| -8% | -$679K |
|
|
PNT
37
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $7.57M | 0.58% |
720,000
+700,000
| +3,500% | +$7.36M |
|
38
Aterian
ATER
$9.65M
| $7.41M | 0.57% |
+251,015
| New | +$7.41M |
|
39
Caesarstone
CSTE
$49.8M
| $7.35M | 0.56% |
+535,148
| New | +$7.35M |
|
40
ARS Pharmaceuticals
SPRY
$1.07B
| $7.32M | 0.56% |
167,799
-6,462
| -4% | -$282K |
|
|
ONC
41
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.1B
| $7.28M | 0.56% |
+20,900
| New | +$7.28M |
|
|
BLSA
42
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $7.27M | 0.56% |
687,900
+62,900
| +10% | +$665K |
|
|
TRIL
43
DELISTED
Trillium Therapeutics Inc.
TRIL
| $7.2M | 0.55% |
670,459
+43,700
| +7% | +$469K |
|
44
Varonis Systems
VRNS
$6.15B
| $7.12M | 0.55% |
138,675
+83,450
| +151% | +$4.28M |
|
45
CyberArk
CYBR
$22.9B
| $7.11M | 0.55% |
+55,000
| New | +$7.11M |
|
46
Dyne Therapeutics
DYN
$1.9B
| $6.99M | 0.54% |
450,064
+350,064
| +350% | +$5.44M |
|
47
Allot
ALLT
$385M
| $6.71M | 0.51% |
420,205
-112,987
| -21% | -$1.8M |
|
48
Sutro Biopharma
STRO
$83.1M
| $6.71M | 0.51% |
294,825
+93,225
| +46% | +$2.12M |
|
|
VRNA
49
Verona Pharma
VRNA
$9.18B
| $6.7M | 0.51% |
801,256
-232,347
| -22% | -$1.94M |
|
50
Cogent Biosciences
COGT
$1.81B
| $6.7M | 0.51% |
762,569
+27,135
| +4% | +$238K |
|